IMM - Immutep Limited
ASX
->
Healthcare
->
Biotechnology
Sydney,
Australia
Type: Equity
IMM price evolution
IMM
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $161.79 | $161.79 | $103.73 | $103.73 |
| Short term investments | $20.09 | $20.09 | ||
| Net receivables | $7.56 | $7.56 | $6.1 | $6.1 |
| Inventory | ||||
| Total current assets | $191.35 | $191.35 | $113.04 | $113.04 |
| Long term investments | ||||
| Property, plant & equipment | $0.68 | $0.68 | $0.8 | $0.8 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $201.58 | $201.58 | $123.79 | $123.79 |
| Current liabilities | ||||
| Accounts payable | $3.79 | $3.79 | $5.87 | $5.87 |
| Deferred revenue | ||||
| Short long term debt | $0.23 | $0.23 | $0.21 | $0.21 |
| Total current liabilities | $10.49 | $10.49 | $6.56 | $6.56 |
| Long term debt | $1.36 | $1.36 | $1.4 | $1.4 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $12.06 | $8.15 | $8.15 | |
| Shareholders' equity | ||||
| Retained earnings | -$382.65 | -$382.65 | -$361.16 | -$361.16 |
| Other shareholder equity | $39.73 | $39.73 | $30.09 | $30.09 |
| Total shareholder equity | $189.52 | $189.52 | $115.64 | $115.64 |
| (in millions $) | 30 Jun 2024 | 30 Jun 2023 | 30 Jun 2022 | 30 Jun 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $161.79 | $123.42 | $80 | $60.13 |
| Short term investments | $20.09 | |||
| Net receivables | $7.56 | $7.97 | $8.37 | $6.12 |
| Inventory | ||||
| Total current assets | $191.35 | $134.97 | $90.81 | $68.42 |
| Long term investments | ||||
| Property, plant & equipment | $0.68 | $0.47 | $0.31 | $0.31 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $201.58 | $147.45 | $102.17 | $82.03 |
| Current liabilities | ||||
| Accounts payable | $3.79 | $5.45 | $2.87 | $1.82 |
| Deferred revenue | ||||
| Short long term debt | $0.23 | $0.18 | $0.17 | $0.21 |
| Total current liabilities | $10.49 | $9.77 | $6.41 | $5.34 |
| Long term debt | $1.36 | $1.04 | $1.56 | $2.61 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $10.98 | $8.09 | $8.76 | |
| Shareholders' equity | ||||
| Retained earnings | -$382.65 | -$339.93 | -$302.34 | -$251.68 |
| Other shareholder equity | $39.73 | $39.79 | $38.67 | $11.53 |
| Total shareholder equity | $189.52 | $136.47 | $94.08 | $73.27 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.87 | $0.87 | $2.06 | $2.06 |
| Cost of revenue | -$10.22 | $10.56 | ||
| Gross Profit | -$9.69 | -$9.69 | $2.06 | $2.06 |
| Operating activities | ||||
| Research & development | $10.56 | $10.56 | $10.22 | $10.22 |
| Selling, general & administrative | $2.03 | $2.03 | $2.4 | $2.4 |
| Total operating expenses | $12.58 | $12.58 | $12.62 | $12.62 |
| Operating income | -$11.71 | -$11.71 | -$10.56 | -$10.56 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | -$0.01 | -$0.01 | -$0.01 | -$0.01 |
| Net income | ||||
| Net income | -$10.74 | -$10.74 | -$10.61 | -$10.61 |
| Income (for common shares) | -$10.74 | -$10.74 | -$10.61 | -$10.61 |
| (in millions $) | 30 Jun 2024 | 30 Jun 2023 | 30 Jun 2022 | 30 Jun 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3.84 | $3.51 | $4.71 | $3.86 |
| Cost of revenue | $41.55 | $36.26 | $31.34 | $17.24 |
| Gross Profit | -$37.7 | -$32.75 | -$26.63 | -$13.37 |
| Operating activities | ||||
| Research & development | $41.55 | $28.79 | $25.34 | $12.02 |
| Selling, general & administrative | $8.85 | $8.68 | $7.21 | $6.28 |
| Total operating expenses | $50.4 | $44.94 | $38.55 | $23.52 |
| Operating income | -$46.56 | -$41.43 | -$33.84 | -$19.66 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | -$0.03 | -$0.02 | -$0.09 | -$0.01 |
| Net income | ||||
| Net income | -$42.72 | -$39.9 | -$32.21 | -$29.9 |
| Income (for common shares) | -$42.72 | -$39.9 | -$32.21 | -$29.9 |
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Net income | -$10.74 | -$10.61 | -$10.61 | -$9.64 |
| Operating activities | ||||
| Depreciation | $0.15 | $0.12 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$8.19 | -$9.23 | -$9.23 | -$11.72 |
| Investing activities | ||||
| Capital expenditures | -$0.01 | -$0.01 | -$0.01 | -$0 |
| Investments | ||||
| Total cash flows from investing | -$10.3 | -$0.21 | -$0.21 | -$0.01 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $50.12 | $40.04 | ||
| Net borrowings | -$0.05 | -$0.06 | -$0.06 | -$0.05 |
| Total cash flows from financing | $47.81 | -$0.22 | -$0.22 | $38.07 |
| Effect of exchange rate | $0.07 | -$0.01 | -$0.01 | $0.08 |
| Change in cash and equivalents | -$9.84 | -$9.84 | $27.52 | |
| (in millions $) | 30 Jun 2024 | 30 Jun 2023 | 30 Jun 2022 | 30 Jun 2021 |
|---|---|---|---|---|
| Net income | -$42.72 | -$39.9 | -$32.21 | -$29.9 |
| Operating activities | ||||
| Depreciation | $0.3 | $0.24 | $0.25 | $2.07 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$34.82 | -$35.36 | -$30.23 | -$17.64 |
| Investing activities | ||||
| Capital expenditures | -$0.08 | -$0.02 | -$0.02 | |
| Investments | ||||
| Total cash flows from investing | -$21.02 | -$0.08 | -$0.02 | -$0.02 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $100.24 | $80.08 | $52.98 | $55.04 |
| Net borrowings | -$0.23 | -$0.21 | -$0.22 | -$0.21 |
| Total cash flows from financing | $95.18 | $76.02 | $50.33 | $52.68 |
| Effect of exchange rate | $0.11 | $0.62 | $1.23 | -$0.51 |
| Change in cash and equivalents | $43.42 | $19.4 | $34.27 | |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $5.85M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$42.70M |
| Revenue Q/Q | -4.84% |
| Revenue Y/Y | 48.53% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | -26.25% |
| ROE | -27.99% |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 18.24 |
| Quick ratio | N/A |